Scientific Reports (Feb 2019)

Tissue Engineered Neural Constructs Composed of Neural Precursor Cells, Recombinant Spidroin and PRP for Neural Tissue Regeneration

  • V. P. Baklaushev,
  • V. G. Bogush,
  • V. A. Kalsin,
  • N. N. Sovetnikov,
  • E. M. Samoilova,
  • V. A. Revkova,
  • K. V. Sidoruk,
  • M. A. Konoplyannikov,
  • P. S. Timashev,
  • S. L. Kotova,
  • K. B. Yushkov,
  • A. V. Averyanov,
  • A. V. Troitskiy,
  • J.-E. Ahlfors

DOI
https://doi.org/10.1038/s41598-019-39341-9
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 18

Abstract

Read online

Abstract We have designed a novel two-component matrix (SPRPix) for the encapsulation of directly reprogrammed human neural precursor cells (drNPC). The matrix is comprised of 1) a solid anisotropic complex scaffold prepared by electrospinning a mixture of recombinant analogues of the spider dragline silk proteins – spidroin 1 (rS1/9) and spidroin 2 (rS2/12) - and polycaprolactone (PCL) (rSS-PCL), and 2) a “liquid matrix” based on platelet-rich plasma (PRP). The combination of PRP and spidroin promoted drNPC proliferation with the formation of neural tissue organoids and dramatically activated neurogenesis. Differentiation of drNPCs generated large numbers of βIII-tubulin and MAP2 positive neurons as well as some GFAP-positive astrocytes, which likely had a neuronal supporting function. Interestingly the SPRPix microfibrils appeared to provide strong guidance cues as the differentiating neurons oriented their processes parallel to them. Implantation of the SPRPix matrix containing human drNPC into the brain and spinal cord of two healthy Rhesus macaque monkeys showed good biocompatibility: no astroglial and microglial reaction was present around the implanted construct. Importantly, the human drNPCs survived for the 3 month study period and differentiated into MAP2 positive neurons. Tissue engineered constructs based on SPRPix exhibits important attributes that warrant further examination in spinal cord injury treatment.